Literature DB >> 2589843

Comparative evaluation of cefazolin and clindamycin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.

J T Mader1, K Adams, L Morrison.   

Abstract

A rabbit model for Staphylococcus aureus osteomyelitis was used to compare treatment with clindamycin and cefazolin. Cefazolin (5 mg/kg), cefazolin (15 mg/kg), and clindamycin (70 mg/kg) were injected subcutaneously every 6 h for 28 days. After treatment, S. aureus was found in bone cultures from 22 of 23 control rabbits, 12 of 22 rabbits treated with cefazolin (5 mg/kg), 12 of 23 rabbits treated with cefazolin (15 mg/kg), and 2 of 20 rabbits treated with clindamycin. Drug concentrations in serum, uninfected bone, and infected bone were measured 30 min after cefazolin or clindamycin was injected into a group of rabbits which had been infected for 3 to 4 weeks. Clindamycin gave the highest concentration in infected and uninfected bone. The results of the study showed that clindamycin was superior to cefazolin in the eradication of S. aureus from infected bone in an experimental model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589843      PMCID: PMC172751          DOI: 10.1128/AAC.33.10.1760

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Antibacterial activity of clindamycin and lincomycin in human bone.

Authors:  K Dornbusch; A Carlström; H Hugo; A Lidström
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

Review 2.  Antibacterial activity and pharmacokinetics of clindamycin.

Authors:  D A Leigh
Journal:  J Antimicrob Chemother       Date:  1981-06       Impact factor: 5.790

3.  Clindamycin in the treatment of osteomyelitis in children: a report of 29 cases.

Authors:  W Rodriguez; S Ross; W Khan; D McKay; P Moskowitz
Journal:  Am J Dis Child       Date:  1977-10

4.  Rapid microassays for clindamycin and gentamicin when present together and the effect of pH and of each on the antibacterial activity of the other.

Authors:  L D Sabath; I Toftegaard
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

5.  Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.

Authors:  J T Mader; L T Morrison; K R Adams
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro.

Authors:  J C Nickel; J B Wright; I Ruseska; T J Marrie; C Whitfield; J W Costerton
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

7.  Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.

Authors:  C W Norden; E Shinners; K Niederriter
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

8.  An electron microscopic study of the effect of clindamycin on adherence of Staphylococcus aureus to bone surfaces.

Authors:  K J Mayberry-Carson; W R Mayberry; B K Tober-Meyer; J W Costerton; D W Lambe
Journal:  Microbios       Date:  1986

9.  Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone.

Authors:  J T Summersgill; L G Schupp; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

10.  Antibiotic levels in infected and sterile subcutaneous abscesses in mice.

Authors:  K A Joiner; B R Lowe; J L Dzink; J G Bartlett
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

View more
  11 in total

1.  Osteomyelitis management: More art than science?

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

2.  Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Authors:  Naïm Bouazza; Vincent Pestre; Vincent Jullien; Emmanuel Curis; Saïk Urien; Dominique Salmon; Jean-Marc Tréluyer
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

3.  Antibiotic penetration into rabbit nucleus pulposus with discitis.

Authors:  Liang Zhang; Jing-cheng Wang; Xin-min Feng; Wei-hua Cai; Jian-dong Yang; Ning Zhang
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-17

4.  Modulation of Staphylococcus aureus Biofilm Matrix by Subinhibitory Concentrations of Clindamycin.

Authors:  Katrin Schilcher; Federica Andreoni; Vanina Dengler Haunreiter; Kati Seidl; Barbara Hasse; Annelies S Zinkernagel
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 5.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 6.  Bone as an effect compartment : models for uptake and release of drugs.

Authors:  David Stepensky; Lilach Kleinberg; Amnon Hoffman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.

Authors:  Valérie Zeller; Arnaud Dzeing-Ella; Marie-Dominique Kitzis; Jean-Marc Ziza; Patrick Mamoudy; Nicole Desplaces
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

Review 8.  Evaluation of quinolones in experimental animal models of infections.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

9.  Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.

Authors:  Borg Leijtens; Joris B W Elbers; Patrick D Sturm; Bart Jan Kullberg; Berend W Schreurs
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090

10.  PCL/Sodium-Alginate Based 3D-Printed Dual Drug Delivery System with Antibacterial Activity for Osteomyelitis Therapy.

Authors:  Ji-Hyun Lee; Jung-Kyu Park; Kuk-Hui Son; Jin-Woo Lee
Journal:  Gels       Date:  2022-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.